Millennium Management LLC Increases Stake in ALX Oncology Holdings Inc.

Millennium Management LLC has filed an amendment to its Schedule 13G, disclosing an increased ownership stake in ALX Oncology Holdings Inc. The filing, dated October 22, 2025, reveals that Millennium Management LLC now holds 3,188,196 shares of ALX Oncology's common stock, representing a 6.0% ownership interest. This marks a significant increase from previous holdings, with the value of the stake rising to $5,228,641.44, a 2,456.99% increase. The filing also includes Integrated Core Strategies (US) LLC, Millennium Group Management LLC, and Israel A. Englander as joint filers, all of whom share voting and dispositive power over the shares. The filing certifies that the shares were not acquired for the purpose of influencing the control of the issuer.